Skip to content

Clinical trials

Observational Lung Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Observational Country / region: United Kingdom Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20112
20121
20162
20172
20191
20202
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Royal Brompton & Harefield NHS Foundation Trust3
Nottingham University Hospitals NHS Trust2
Guy's and St Thomas' NHS Foundation Trust1
Hull University Teaching Hospitals NHS Trust1
Imperial College London1
Liverpool Heart and Chest Hospital NHS Foundation Trust1
University of Lincoln1
XDx1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases14
Pulmonary Disease, Chronic Obstructive6
Respiratory Tract Diseases4
Lung Diseases, Obstructive3
Asthma2
Bronchitis, Chronic2
COVID-192
Cystic Fibrosis2
Digestive System Diseases2
Disease Progression2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.